HanchorBio Inc. (TPEX:7827)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
143.00
-1.50 (-1.04%)
At close: Apr 17, 2026
Market Cap18.59B
Revenue (ttm)312.22M
Net Income-497.62M
EPS-4.43
Shares Out130.01M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume978,291
Average Volume501,912
Open144.00
Previous Close144.50
Day's Range137.50 - 148.50
52-Week Range41.80 - 179.00
Betan/a
RSI57.46
Earnings DateApr 28, 2026

About HanchorBio

HanchorBio Inc. operates as a biotechnology company that develops biologics for cancer patients. The company offers FBDB platform to develop biological medicines. The company also engages in novel target research and evaluation, development of in vitro and in vivo models for evaluating the bioactivities of anti-cancer drugs, and development of proteins. HanchorBio Inc. was founded in 2020 and is based in Taipei, Taiwan with an additional office in Shanghai, China. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2020
Country Cayman Islands
Stock Exchange Taipei Exchange
Ticker Symbol 7827
Full Company Profile

Financial Performance

Financial Statements